default author photo

Eneda Toska

Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program

United States

SCHOLARLY PAPERS

1

DOWNLOADS

122

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

Number of pages: 51 Posted: 17 Dec 2019
Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center - Cancer Biology and Genetics Program, Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, Memorial Sloan Kettering Cancer Center - Department of Medicine, Memorial Sloan Kettering Cancer Center - Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center - Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, University of Torino - Department of Oncology, FPO-IRCCS - Candiolo Cancer Institute, Memorial Sloan Kettering Cancer Center - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center - Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute - Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute - Department of Drug Discovery, University of Torino - Department of Oncology, Memorial Sloan Kettering Cancer Center - Department of Pathology, Memorial Sloan Kettering Cancer Center - Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center - Department of Medicine, Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, Memorial Sloan Kettering Cancer Center - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center - Department of Medicine and Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program
Downloads 122 (588,531)

Abstract:

Loading...

drug resistance, tyrosine kinase inhibitors, cancer, signaling